Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal misoprostol versus gum chewing for return of bowel function after elective caesarean section
PACTR202410788598848Phase 3Not yet recruiting
- Sponsor
- HADIJAT AREMU
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of misoprostol in postoperative ileus (POI) and puerperium (PP) (3 arms), sponsored by HADIJAT AREMU. Primary endpoints: Time to first flatus, Time to normal bowel sounds and 2 more. Planned start May 2024; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
postoperative ileus (POI)puerperium (PP)
Beyond the preview
Go deeper on PACTR202410788598848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202410788598848.